Number of OTC products | N | % |
---|---|---|
1 | 105 | 37.4 |
2 | 79 | 28.1 |
3 | 48 | 17.1 |
4 | 20 | 7.1 |
5 | 14 | 5 |
6 | 8 | 2.8 |
7 | 3 | 1.1 |
8 | 3 | 1.1 |
9 | 1 | 0.4 |
Mean (SD) | 2.35 | (1.57) |
Median | 2.00 | |
Age group | ||
65–69 | 56 | 19.9 |
70–74 | 58 | 20.6 |
75–79 | 56 | 19.9 |
80–84 | 60 | 21.4 |
85–89 | 32 | 11.4 |
90+ | 19 | 6.8 |
Mean (SD) | 77.0 | (7.5) |
Median | 76.0 | |
Gender | ||
Males | 141 | 50.2 |
Females | 140 | 49.8 |
Number of comorbidities | ||
1 | 1 | 0.4 |
2 | 2 | 0.7 |
3 | 16 | 5.7 |
4 | 52 | 18.5 |
5 | 39 | 13.9 |
6 | 37 | 13.2 |
7 | 42 | 14.9 |
8 | 40 | 14.2 |
9 | 29 | 10.3 |
10 | 9 | 3.2 |
11 | 4 | 1.4 |
12 | 4 | 1.4 |
13 | 1 | 0.4 |
14 | 3 | 1.1 |
15 | 1 | 0.4 |
16 | 1 | 0.4 |
Mean (SD) | 6.5 | (2.4) |
Median | 6.0 |